DK0634175T3 - Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist - Google Patents

Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist

Info

Publication number
DK0634175T3
DK0634175T3 DK94110064T DK94110064T DK0634175T3 DK 0634175 T3 DK0634175 T3 DK 0634175T3 DK 94110064 T DK94110064 T DK 94110064T DK 94110064 T DK94110064 T DK 94110064T DK 0634175 T3 DK0634175 T3 DK 0634175T3
Authority
DK
Denmark
Prior art keywords
inhibitor
renin
pharmaceutical combination
angiotensin system
endothelin antagonist
Prior art date
Application number
DK94110064T
Other languages
Danish (da)
English (en)
Inventor
Jean-Paul Clozel
Martine Clozel
Wolfgang Osterrieder
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0634175T3 publication Critical patent/DK0634175T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK94110064T 1993-07-15 1994-06-29 Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist DK0634175T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH213193 1993-07-15

Publications (1)

Publication Number Publication Date
DK0634175T3 true DK0634175T3 (da) 2001-04-30

Family

ID=4226611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94110064T DK0634175T3 (da) 1993-07-15 1994-06-29 Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist

Country Status (25)

Country Link
US (1) US5696116A (ru)
EP (1) EP0634175B1 (ru)
JP (1) JP2746537B2 (ru)
KR (1) KR100370181B1 (ru)
CN (1) CN1105573C (ru)
AT (1) ATE198551T1 (ru)
AU (1) AU683262B2 (ru)
BR (1) BR9402815A (ru)
CA (1) CA2128142C (ru)
CZ (1) CZ285413B6 (ru)
DE (1) DE59409631D1 (ru)
DK (1) DK0634175T3 (ru)
ES (1) ES2154277T3 (ru)
GR (1) GR3035702T3 (ru)
HU (1) HU221202B1 (ru)
IL (1) IL110272A (ru)
NO (1) NO312578B1 (ru)
NZ (1) NZ260969A (ru)
PL (1) PL176445B1 (ru)
PT (1) PT634175E (ru)
RU (1) RU2146522C1 (ru)
SA (1) SA94150155B1 (ru)
TW (1) TW287949B (ru)
UA (1) UA27870C2 (ru)
ZA (1) ZA944980B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
CN1211183A (zh) 1996-02-20 1999-03-17 布里斯托尔-迈尔斯斯奎布公司 联苯基异噁唑磺酰胺的制备方法
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
JP4917707B2 (ja) * 1997-09-26 2012-04-18 アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト エンドセリン拮抗剤およびレニン−アンギオテンシン系阻害剤から成る組合せ剤
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
DE122007000055I1 (de) * 1998-07-10 2007-12-13 Novartis Pharma Ag Bluthochdruckgegenmittel-Kombination des valsartanund kalziumkanal Blocker
US6136971A (en) * 1998-07-17 2000-10-24 Roche Colorado Corporation Preparation of sulfonamides
CN101011390A (zh) * 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
EP1165472A4 (en) 1999-03-19 2002-11-20 Bristol Myers Squibb Co METHOD FOR PRODUCING BIPHENYL ISOXAZOLE
DK1695703T3 (da) * 2000-08-25 2010-10-25 Res Corp Technologies Inc Nye anvendelser for aminosyrekrampestillende midler
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
DE60309472T2 (de) * 2002-06-28 2007-06-28 Speedel Pharma Ag Pharmazeutische formulierung mit einem nicht peptidischen renin-hemmer und surfactant
EP1660089A1 (en) * 2003-08-22 2006-05-31 Schering Aktiengesellschaft Chemokine inhibiting piperazine derivatives and their use to treat myocarditis
RU2423127C2 (ru) * 2005-12-06 2011-07-10 Сантен Фармасьютикал Ко., Лтд. Терапевтическое средство против роговично-конъюнктивального нарушения
WO2008073927A1 (en) * 2006-12-12 2008-06-19 Gilead Colorado, Inc. Ambrisentan combined with a renin inhibitor for hypertensive disorder
WO2008088727A2 (en) 2007-01-12 2008-07-24 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8080549B2 (en) * 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR20230074610A (ko) * 2017-02-27 2023-05-30 이도르시아 파마슈티컬스 리미티드 엔도텔린 관련 질환의 치료를 위한 4-피리미딘술파미드 유도체와 활성 성분의 조합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
AT377496B (de) * 1981-06-19 1985-03-25 Voith Gmbh J M Vorrichtung zum anwickeln einer warenbahn auf eine neu eingelegte wickelhuelse in einer doppeltragwalzen-wickelmaschine
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
EP0334164B1 (de) * 1988-03-24 1993-10-27 F. Hoffmann-La Roche Ag Antihypertensives Kombinationspräparat
CA2100171A1 (en) * 1991-01-31 1992-08-01 Kazumi Shiosaki Endothelin converting enzyme inhibitors
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
DK0498722T3 (da) * 1991-02-07 1998-03-09 Roussel Uclaf Nye bicycliske nitrogenforbindelser substitueret med en benzylgruppe, fremgangsmåde til deres fremstilling, de opnåede nye intermediærer, deres anvendelse som lægemidler og de pharmaceutiske præparater som de indgår i
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW216770B (ru) * 1991-07-23 1993-12-01 Hoffmann La Roche
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists

Also Published As

Publication number Publication date
JPH0753408A (ja) 1995-02-28
PL304292A1 (en) 1995-01-23
NO312578B1 (no) 2002-06-03
PL176445B1 (pl) 1999-05-31
EP0634175B1 (de) 2001-01-10
HU221202B1 (en) 2002-08-28
KR960013371A (ko) 1996-05-22
ES2154277T3 (es) 2001-04-01
GR3035702T3 (en) 2001-07-31
UA27870C2 (uk) 2000-10-16
RU94026283A (ru) 1996-05-20
AU6735794A (en) 1995-01-27
DE59409631D1 (de) 2001-02-15
TW287949B (ru) 1996-10-11
CA2128142C (en) 2007-03-06
HUT67331A (en) 1995-03-28
NZ260969A (en) 1996-01-26
PT634175E (pt) 2001-06-29
IL110272A0 (en) 1994-10-21
CA2128142A1 (en) 1995-01-16
AU683262B2 (en) 1997-11-06
NO942650D0 (no) 1994-07-14
CN1105573C (zh) 2003-04-16
SA94150155B1 (ar) 2005-11-15
RU2146522C1 (ru) 2000-03-20
BR9402815A (pt) 1995-04-04
CZ285413B6 (cs) 1999-08-11
NO942650L (no) 1995-01-16
EP0634175A1 (de) 1995-01-18
CN1107364A (zh) 1995-08-30
JP2746537B2 (ja) 1998-05-06
KR100370181B1 (ko) 2003-04-26
CZ167794A3 (en) 1995-01-18
US5696116A (en) 1997-12-09
ZA944980B (en) 1995-02-06
IL110272A (en) 1998-07-15
ATE198551T1 (de) 2001-01-15
HU9402064D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
DK0634175T3 (da) Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist
NO932620L (no) Amindiol-proteaseinhibitorer
NO962162L (no) Dipeptider som bevirker frigjöring av veksthormon
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
DE69620161D1 (de) Thrombininhibitoren
TR199701056T1 (xx) Farnesil-protein transferaz enzimi inhibit�rleri.
DE69528528T2 (de) Thrombin-inhibitoren
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE60118774D1 (de) Substituierte phenolderivate und deren salze als hemmstoffe von koagulations faktor x
ATE287402T1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
ATE305781T1 (de) Non-peptidische vasopressin via antagonisten
DE69838042D1 (de) Verwendung von Inhibitoren des Renin-Angiotensin Systems
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
NO924680D0 (no) Sveisbar primer for staal
ATE295168T1 (de) Zusammensetzung von riluzol und alpha-tocopherol
EP0653208A3 (en) Substance P antagonists for the treatment or prevention of sunburn.
DK0891778T3 (da) TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser
ES2106098T3 (es) Lacidipino para el tratamiento de la arteriosclerosis.
ITVR930071A0 (it) Procedimento per la registrazione e/o il controllo di operazioni succedentisi nel tempo in ambienti di tipo industriale.